Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis
- PMID: 20862503
- DOI: 10.1007/s10067-010-1561-9
Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis
Abstract
A 56-year old patient with a history of limited Wegener's granulomatosis presented with signs and symptoms of optic neuritis. Radiologic signs of orbital inflammation were absent. Testing of visual acuity and visual field allowed close monitoring of disease activity. Thus, rapid improvement of visual function was achieved with high-dose steroids. Despite maintenance therapy with cyclophosphamide recurrence occurred repeatedly as soon as tapering of steroids was begun. After remission induction with rituximab, the patient retained good visual function under maintenance therapy with azathioprine and low-dose corticosteroids. Optic neuritis in Wegener's granulomatosis without signs of orbital involvement is rare and most likely caused by occlusive vasculitis of the vasa nervorum. In this patient with optic neuritis refractory to conventional therapy, rituximab in combination with cyclophosphamide and corticosteroids was well tolerated and successfully used for remission induction, followed by maintenance therapy with azathioprine and low dose corticosteroids.
Similar articles
-
Advances in the therapy of Wegener's granulomatosis.Curr Opin Rheumatol. 2006 Jan;18(1):25-32. doi: 10.1097/01.bor.0000200369.24793.f5. Curr Opin Rheumatol. 2006. PMID: 16344616 Review.
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.Ann Rheum Dis. 2015 Jun;74(6):1178-82. doi: 10.1136/annrheumdis-2014-206404. Epub 2015 Mar 4. Ann Rheum Dis. 2015. PMID: 25739829 Clinical Trial.
-
Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.Prescrire Int. 2015 Jun;24(161):145-8. Prescrire Int. 2015. PMID: 26436161 Review.
-
Maintaining remission in a patient with vasculitis.Nat Clin Pract Rheumatol. 2008 Sep;4(9):499-504. doi: 10.1038/ncprheum0863. Epub 2008 Jul 22. Nat Clin Pract Rheumatol. 2008. PMID: 18648340
-
[Treatment of ANCA-associated vascularitides].Presse Med. 2007 May;36(5 Pt 2):922-7. doi: 10.1016/j.lpm.2007.01.029. Epub 2007 Apr 3. Presse Med. 2007. PMID: 17408912 Review. French.
Cited by
-
Optic neuropathy as an early manifestation of granulomatosis with polyangiitis: a case report and literature review.Front Med (Lausanne). 2025 Feb 18;12:1515622. doi: 10.3389/fmed.2025.1515622. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40041467 Free PMC article.
-
Dynamic Immune Cell Recruitment After Murine Pulmonary Aspergillus fumigatus Infection under Different Immunosuppressive Regimens.Front Microbiol. 2016 Jul 13;7:1107. doi: 10.3389/fmicb.2016.01107. eCollection 2016. Front Microbiol. 2016. PMID: 27468286 Free PMC article.
-
Association between Sjögren syndrome, sociodemographic factors, comorbid conditions, and optic neuritis: a Taiwanese population-based study.Front Neurol. 2024 Feb 27;15:1353326. doi: 10.3389/fneur.2024.1353326. eCollection 2024. Front Neurol. 2024. PMID: 38476197 Free PMC article.
-
Successful Combination Therapy with Rituximab and Glucocorticoids for Autoimmune Optic Neuropathy.Am J Case Rep. 2015 Jun 9;16:357-60. doi: 10.12659/AJCR.894064. Am J Case Rep. 2015. PMID: 26057570 Free PMC article.
-
Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):871-7. doi: 10.1007/s00417-011-1896-1. Epub 2011 Dec 15. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 22169982
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical